PATENT CLAIM ANALYSIS

Application Number: 15757273
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "025000"]

Abstract:
The invention relates to the use of secoisolariciresinol diglucoside (SDG), other active components in flaxseed, and related compounds for treating proton radiation associated lung injury and protecting normal lung tissue against proton radiation exposure. The invention also relates to the use of SDG, other active components in flaxseed, and related compounds in down-regulating senescence markers, and thereby protecting from senescence associated or radiation induced aging phenotypes.

Claim (Index 55):
A method for treating or preventing radiation damage in a subject who has been or will be exposed to radiation, the method comprising: administering to said subject an effective amount of at least one bioactive ingredient, wherein said bioactive ingredient comprises secoisolaricirecinol diglucoside (SDG), secoisolariciresinol (SECO), enterodiol (ED), enterolactone (EL), metabolites thereof, degradants thereof, analogs thereof, stereoisomers thereof, or a combination thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.70455
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13084408', '14083804', '12601882', '12184451', '10861948']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.772697849409685
- 35 USC 102 Novelty (BERT): 0.548540738691363
- Combined Prediction Score: 0.7502821383378528
- Mean Citation Score: 312.465796
- Max Citation Score: 415.50195
- Similarity Product: 322.31928992894586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test